Dimensional Fund Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.1M | Sell |
|
|||||
|
2025
Q1 | $78.3M | Buy |
|
|||||
|
2024
Q4 | $77.5M | Buy |
|
|||||
|
2024
Q3 | $70.8M | Sell |
|
|||||
|
2024
Q2 | $59.7M | Buy |
|
|||||
|
2024
Q1 | $48.5M | Buy |
|
|||||
|
2023
Q4 | $47.2M | Buy |
|
|||||
|
2023
Q3 | $36.8M | Buy |
|
|||||
|
2023
Q2 | $38.3M | Buy |
|
|||||
|
2023
Q1 | $34.6M | Buy |
|
|||||
|
2022
Q4 | $30.6K | Sell |
|
|||||
|
2022
Q3 | $38.7M | Buy |
|
|||||
|
2022
Q2 | $39.5M | Buy |
|
|||||
|
2022
Q1 | $42.5M | Buy |
|
|||||
|
2021
Q4 | $57.6M | Sell |
|
|||||
|
2021
Q3 | $51.9M | Sell |
|
|||||
|
2021
Q2 | $53.7M | Buy |
|
|||||
|
2021
Q1 | $55.2M | Sell |
|
|||||
|
2020
Q4 | $36.4M | Sell |
|
|||||
|
2020
Q3 | $36.2M | Sell |
|
|||||
|
2020
Q2 | $42.8M | Sell |
|
|||||
|
2020
Q1 | $33.6M | Sell |
|
|||||
|
2019
Q4 | $49M | Buy |
|
|||||
|
2019
Q3 | $39.1M | Buy |
|
|||||
|
2019
Q2 | $26.6M | Buy |
|
|||||
|
2019
Q1 | $26.7M | Buy |
|
|||||
|
2018
Q4 | $28.1M | Buy |
|
|||||
|
2018
Q3 | $48.1M | Sell |
|
|||||
|
2018
Q2 | $41.2M | Sell |
|
|||||
|
2018
Q1 | $36.7M | Sell |
|
|||||
|
2017
Q4 | $30.9M | Sell |
|
|||||
|
2017
Q3 | $32.3M | Sell |
|
|||||
|
2017
Q2 | $32M | Sell |
|
|||||
|
2017
Q1 | $28.4M | Sell |
|
|||||
|
2016
Q4 | $27.3M | Sell |
|
|||||
|
2016
Q3 | $27.4M | Sell |
|
|||||
|
2016
Q2 | $34.3M | Sell |
|
|||||
|
2016
Q1 | $39.2M | Sell |
|
|||||
|
2015
Q4 | $59.8M | Sell |
|
|||||
|
2015
Q3 | $47.9M | Buy |
|
|||||
|
2015
Q2 | $55.6M | Buy |
|
|||||
|
2015
Q1 | $40M | Buy |
|
|||||
|
2014
Q4 | $23.1M | Buy |
|
|||||
|
2014
Q3 | $18.7M | Buy |
|
|||||
|
2014
Q2 | $23.1M | Buy |
|
|||||
|
2014
Q1 | $14.9M | Buy |
|
|||||
|
2013
Q4 | $6.66M | Buy |
|
|||||
|
2013
Q3 | $37K | Hold |
|
|||||
|
2013
Q2 | $32K | Buy |
|